[Skip to content]

Print this page

7.1 Drugs used in obstetrics

7.1.1    Prostaglandins and oxytocics

Carboprost injection
Dinoprostone tablets, vaginal gel, vaginal tablets, IV solution, extra-amniotic solution
Dinoprost intra-amniotic injection
Ergometrine injection
Ergometrine + Oxytocin ("Syntrometrine")
Gemeprost pessaries
Oxytocin injection Ductus arteriosus

Indometacin injection


7.1.2    Mifepristone

Mifepristone tablets


7.1.3    Myometrial relaxants

Atosiban Infusion


Short-acting β2 agonists restricted use for tocolysis in premature labour
Myocardial ischaemia may occur with use of short-acting β agonists: patients with pre-existing ischaemic heart disease or risk factors for cardiovascular disease should not be given short-acting β agonists for management of premature labour, and should be alert to symptoms of worsening heart disease if receiving treatment for respiratory disease e.g. ritodrine,salbutamol. Also, the use of short-acting β2 agonists for tocolysis in premature labour has been restricted to 48 hours’ maximum parenteral use under specialist supervision, after a European safety review.This does not apply to atosiban. See DSU November 2013


For link to BNF section: 7.1 Drugs used in obstetrics